Literature DB >> 1703429

[Plastic surgical enlargement of the anterior annular carpal ligament in the treatment of carpal tunnel syndrome].

A I Kapandji1.   

Abstract

In the treatment of the carpal tunnel syndrome the simple division of the transverse carpal ligament sometimes causes a certain weakness of the grip strength, which takes a very long to recover. In order to avoid this inconvenience, a new technique is described consisting in an enlargement plasty of the transverse carpal ligament. The procedure is simple but precise: it consists in a zigzag incision making two flaps and suturing them over a gauge. It needs a great attention during the first stage not to accidentally wound the thenar branch of the median nerve. The division of the subcutaneous part of the ligament and the measuring of the enlargement is facilitated by a new instrument, the "Cat-Tongue Gauge" which is described there. If necessary, a pre-operative CT scan and another one performed three months later confirm the reconstruction of the ligament and the enlargement of the carpal tunnel. In 46 wrists, we observed no complications and rapid rehabilitation. Some rare painful scars can be avoided by a good location of the incision in the vertical hypothenar crease and by a precise dissection of the subcutaneous tissues. The strength of the grip seems to be recovered sooner than with the classical technique; a prospective study is started to confirm this point.

Entities:  

Mesh:

Year:  1990        PMID: 1703429     DOI: 10.1016/s0753-9053(05)80180-2

Source DB:  PubMed          Journal:  Ann Chir Main Memb Super        ISSN: 1153-2424


  2 in total

1.  Changes in grip strength in a randomized study of carpal tunnel release by three different techniques.

Authors:  G Foucher; L Van Overstraeten; J Braga da Silva; D Nolens
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-03-10

2.  Carpal tunnel release with versus without flexor retinaculum reconstruction for carpal tunnel syndrome at short- and long-term follow up-A meta-analysis of randomized controlled trials.

Authors:  Sike Lai; Kaibo Zhang; Jian Li; Weili Fu
Journal:  PLoS One       Date:  2019-01-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.